These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31350667)
1. Multidimensional assessment of fatigue in patients with brain metastases before and after Gamma Knife radiosurgery. Verhaak E; Schimmel WCM; Sitskoorn MM; Bakker M; Hanssens PEJ; Gehring K J Neurooncol; 2019 Sep; 144(2):377-384. PubMed ID: 31350667 [TBL] [Abstract][Full Text] [Related]
2. The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery. Verhaak E; Schimmel WCM; Sitskoorn MM; Hanssens PEJ; Butterbrod E; Gehring K J Cancer Res Clin Oncol; 2023 Sep; 149(12):9891-9901. PubMed ID: 37249646 [TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery. Verhaak E; Gehring K; Hanssens PEJ; Sitskoorn MM J Neurooncol; 2019 Jul; 143(3):537-546. PubMed ID: 31073966 [TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life after Gamma Knife radiosurgery in patients with 1-10 brain metastases. Verhaak E; Schimmel WCM; Gehring K; Emons WHM; Hanssens PEJ; Sitskoorn MM J Cancer Res Clin Oncol; 2021 Apr; 147(4):1157-1167. PubMed ID: 33025282 [TBL] [Abstract][Full Text] [Related]
5. Quality of life is maintained using Gamma Knife radiosurgery: a prospective study of a brain metastases patient cohort. Skeie BS; Eide GE; Flatebø M; Heggdal JI; Larsen E; Bragstad S; Pedersen PH; Enger PØ J Neurosurg; 2017 Mar; 126(3):708-725. PubMed ID: 27058206 [TBL] [Abstract][Full Text] [Related]
6. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304 [TBL] [Abstract][Full Text] [Related]
7. Cognitive functioning and predictors thereof in patients with 1-10 brain metastases selected for stereotactic radiosurgery. Schimmel WCM; Gehring K; Hanssens PEJ; Sitskoorn MM J Neurooncol; 2019 Nov; 145(2):265-276. PubMed ID: 31552588 [TBL] [Abstract][Full Text] [Related]
8. Group and Individual Change in Cognitive Functioning in Patients With 1 to 10 Brain Metastases Following Gamma Knife Radiosurgery. Schimmel WCM; Verhaak E; Bakker M; Hanssens PEJ; Sitskoorn MM; Gehring K Clin Oncol (R Coll Radiol); 2021 May; 33(5):314-321. PubMed ID: 33531195 [TBL] [Abstract][Full Text] [Related]
9. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery. Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640 [TBL] [Abstract][Full Text] [Related]
10. Concomitant radiosurgical and targeted oncological treatment improves the outcome of patients with brain metastases from gastrointestinal cancer. Khalaveh F; Cho A; Shaltout A; Untersteiner H; Kranawetter B; Hirschmann D; Göbl P; Marik W; Gatterbauer B; Rössler K; Dorfer C; Frischer JM Radiat Oncol; 2023 Dec; 18(1):197. PubMed ID: 38071299 [TBL] [Abstract][Full Text] [Related]
11. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis. Zubatkina I; Ivanov P J Neurosurg; 2018 Aug; 129(2):354-365. PubMed ID: 28841116 [TBL] [Abstract][Full Text] [Related]
12. Gamma knife radiosurgery in non small cell lung cancer patients with brain metastases: treatment results and prognostic factors. Abacioglu U; Caglar H; Atasoy BM; Abdulloev T; Akgun Z; Kilic T J BUON; 2010; 15(2):274-80. PubMed ID: 20658721 [TBL] [Abstract][Full Text] [Related]
13. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401). Kawabe T; Yamamoto M; Sato Y; Yomo S; Kondoh T; Nagano O; Serizawa T; Tsugawa T; Okamoto H; Akabane A; Aita K; Sato M; Jokura H; Kawagishi J; Shuto T; Kawai H; Moriki A; Kenai H; Iwai Y; Gondo M; Hasegawa T; Yasuda S; Kikuchi Y; Nagatomo Y; Watanabe S; Hashimoto N J Neurosurg; 2016 Dec; 125(Suppl 1):11-17. PubMed ID: 27903179 [TBL] [Abstract][Full Text] [Related]
14. Cognitive Functioning and Health-Related Quality of Life of Long-Term Survivors With Brain Metastases Up to 21 Months After Gamma Knife Radiosurgery. Verhaak E; Schimmel WCM; Gehring K; Hanssens PEJ; Sitskoorn MM Neurosurgery; 2021 Apr; 88(5):E396-E405. PubMed ID: 33575811 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of gamma knife radiosurgery, bi-modality & tri-modality treatment regimens for patients with one or multiple brain metastases: the Columbia University Medical Center experience. Wang TJ; Saad S; Qureshi YH; Jani A; Isaacson SR; Sisti MB; Bruce JN; McKhann GM; Lesser J; Cheng SK; Clifford Chao KS; Lassman AB J Neurooncol; 2015 Apr; 122(2):399-408. PubMed ID: 25687652 [TBL] [Abstract][Full Text] [Related]
16. Gamma knife radiosurgery for elderly patients with brain metastases: evaluation of scoring systems that predict survival. Park JY; Moon KS; Lee KH; Lim SH; Jang WY; Lee H; Jung TY; Kim IY; Jung S BMC Cancer; 2015 Feb; 15():54. PubMed ID: 25885321 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723 [TBL] [Abstract][Full Text] [Related]
19. Outcomes and predictors of improved survival after gamma knife radiosurgery for metastatic brain tumors originated from breast carcinoma. Bir SC; Bollam P; Nanda A Neurosurg Rev; 2015 Jul; 38(3):489-98; discussion 498. PubMed ID: 25843300 [TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life after stereotactic radiosurgery in patients with brain metastases. Albers EAC; de Ligt KM; van de Poll-Franse LV; Compter A; de Ruiter MB; Schagen SB Support Care Cancer; 2023 Nov; 31(12):720. PubMed ID: 38008876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]